Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000899243-21-035442

Chief Executive Officer bought 11,000 shares at $8.73 ($96,066)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SOUTHWELL DAVID P Chief Executive Officer 2021-09-08 Purchase +11,000 $8.73 $96,066 97,899 D
Open-market purchases · 11,000 sh · avg $8.73 · $96,066
Loading xslF345X03/doc4.xml…